Central Canal Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The central canal of the spinal cord represents a fundamental anatomical structure that houses a specialized population of neurons critical for autonomic integration, sensory processing, and nervous system development. These neurons, surrounding the ependymal-lined central canal, play vital roles in health and disease, serving as an essential interface between cerebrospinal fluid (CSF) and the spinal cord parenchyma[1].
The central canal is a narrow, fluid-filled passage extending throughout the length of the spinal cord, from the caudal medulla oblongata to the conus medullaris at approximately L1-L2 vertebral levels in adults[2]. In embryonic development, the central canal forms from the neural tube's lumen and persists as a vestigial structure in adulthood, though it often becomes partially or completely obliterated with age[3].
The neurons surrounding the central canal (often termed "central canal neurons" or "canal neurons") are primarily located in the lamina X region, also known as the commissural nucleus. This region surrounds the canal and extends dorsally toward the dorsal horn and ventrally toward the ventral horn[4].
The central canal region contains several distinct neuronal populations:
GABAergic neurons: These inhibitory neurons express glutamic acid decarboxylase (GAD65/67) and provide local inhibition to modulate sensory and autonomic signals[5].
Glutamatergic neurons: Using vesicular glutamate transporter 2 (vGluT2), these excitatory neurons process visceral and somatic sensory information[6].
Cholinergic neurons: A subset of neurons expressing choline acetyltransferase (ChAT) contributes to autonomic regulation[7].
Calretinin- and calbindin-expressing neurons: These calcium-binding protein markers identify specific subpopulations with distinct physiological properties[8].
Central canal neurons derive from the ventricular zone of the neural tube during embryogenesis. The progenitor domains follow a dorsal-ventral patterning established by morphogen gradients, particularly sonic hedgehog (SHH) from the floor plate and bone morphogenetic proteins (BMPs) from the roof plate[9].
In neonates, the central canal remains patent and actively communicates with the ventricular system. The ependymal cells lining the canal possess beating cilia that promote CSF circulation. By adulthood, the canal often narrows or closes in many individuals, though functional significance of this variability remains unclear[10].
The central canal region serves as a crucial hub for autonomic function:
Visceral sensory processing: Neurons in this region receive input from visceral afferents traveling in the vagus nerve and pelvic nerves, integrating information about organ status[11].
Cardiovascular regulation: Connections to the nucleus of the solitary tract (NTS), caudal ventrolateral medulla (CVLM), and rostral ventrolateral medulla (RVLM) enable modulation of blood pressure and heart rate[12].
Bladder function: The region participates in micturition reflexes, receiving input from the bladder wall and coordinating output to urinary sphincter motoneurons[13].
Central canal neurons contribute to pain processing through:
Local circuit modulation: GABAergic neurons in lamina X modulate dorsal horn pain transmission neurons, influencing nociceptive sensitivity[14].
Descending modulation: Projections to brainstem pain-modulatory regions including the periaqueductal gray (PAG) and nucleus raphe magnus enable endogenous pain control systems[15].
The central canal region provides an interface for CSF-borne signaling molecules:
Chemokine and cytokine signaling: Neurons express receptors for molecules including TNF-alpha, IL-1beta, and CCL2, enabling responses to neuroinflammation[16].
Neurotransmitter metabolites: CSF contains breakdown products of CNS neurotransmission that may modulate neuronal activity in this region[17].
Central canal neurons exhibit diverse electrophysiological characteristics:
Tonic firing: Many neurons display regular, steady-state firing in response to maintained depolarization[18].
Phasic firing: Some neurons show transient responses that adapt during sustained input, potentially serving filter functions[19].
Burst firing: A subpopulation exhibits rhythmic bursting behavior, which may relate to specific autonomic or oscillatory functions[20].
These neurons receive diverse synaptic input:
Primary afferents: Visceral afferents via the dorsal root ganglia terminate on lamina X neurons[21].
Supraspinal inputs: Descending projections from the paraventricular nucleus of the hypothalamus, NTS, and other autonomic centers provide modulatory input[22].
Local interneurons: Intrinsic spinal cord circuits enable integration with dorsal horn and ventral horn neurons[23].
| Neurotransmitter | Marker | Function |
|---|---|---|
| GABA | GAD65/67, VGAT | Inhibition |
| Glutamate | vGluT1/2, CaMKII | Excitation |
| Acetylcholine | ChAT, VAChT | Modulation |
| Glycine | GlyT2 | Inhibition |
| Serotonin | TPH2, 5-HT | Modulation |
Central canal neurons express various receptor types:
Ionotropic glutamate receptors: NMDA, AMPA, and kainate receptors mediate fast excitatory transmission[24].
Metabotropic receptors: Group I-III mGluRs enable modulatory signaling[25].
Monoamine receptors: 5-HT1A, alpha2-adrenergic, and dopaminergic receptors permit neuromodulation[26].
MSA is characterized by progressive autonomic failure, and central canal region involvement is increasingly recognized:
Autonomic dysfunction: Degeneration of preganglionic autonomic neurons in the spinal cord contributes to orthostatic hypotension, urinary dysfunction, and erectile dysfunction[27].
Alpha-synuclein pathology: Oligodendroglial cytoplasmic inclusions (GCIs) in the central canal region have been reported, though neuronal loss in this specific region requires further characterization[28].
Autonomic manifestations: Many PD patients exhibit autonomic dysfunction, including bladder dysfunction, constipation, and orthostatic hypotension, implicating possible central canal involvement[29].
Alpha-synuclein deposition: Lewy bodies have been identified in autonomic regions of the spinal cord, potentially affecting central canal neurons[30].
Autonomic dysreflexia: Following cervical or high thoracic spinal cord injury, exaggerated autonomic responses to visceral stimuli may involve maladaptive changes in central canal neurons[31].
Neuropathic pain: Alterations in GABAergic signaling in lamina X contribute to chronic pain syndromes following spinal cord injury[32].
Autonomic involvement: Some ALS patients develop autonomic dysfunction, and spinal cord autonomic neurons may be affected in sporadic cases[33].
Excitotoxicity: Dysregulated glutamate handling in central canal neurons may contribute to vulnerability in ALS[34].
Rodent studies: Mice and rats provide accessible models for studying central canal neuron development, connectivity, and function[35].
Transgenic models: Genetic models of neurodegeneration, including alpha-synuclein transgenic mice, enable study of pathology in this region[36].
Brain slice preparations: Patch clamp recordings from acute spinal cord slices enable electrophysiological characterization[37].
Stem cell differentiation: Protocols for generating spinal cord neurons from pluripotent stem cells offer potential for disease modeling[38].
MRI changes: Advanced MRI techniques may detect pathological changes in the central canal region in neurodegenerative conditions[39].
CSF biomarkers: Analysis of CSF from the central canal (via cisterna magna puncture) may provide information about spinal cord pathology[40].
Deep brain stimulation: Emerging targets in the spinal cord for autonomic disorders may involve modulation of central canal circuits[41].
Pharmacological approaches: Drugs targeting GABAergic or glutamatergic signaling in this region may have therapeutic potential[42].
Immunohistochemistry: Antibody staining for specific neuronal markers enables detailed characterization of cell populations[43].
Fluorophore injection: Retrograde and anterograde tracing reveals connectivity patterns[44].
Electrophysiology: In vivo and in vitro recordings characterize firing properties and synaptic connections[45].
Optogenetics: Light-activated proteins enable precise manipulation of specific neuronal populations[46].
Central canal neurons in the spinal cord represent a specialized population critical for autonomic integration, sensory processing, and neural-immune interactions. Their strategic position surrounding the central canal, combined with diverse neurochemical properties and extensive connectivity, positions them as important players in both normal physiology and neurodegenerative disease. Understanding these neurons provides insights into autonomic dysfunction, pain processing, and potential therapeutic approaches for neurological conditions affecting the spinal cord.
Central Canal Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Central Canal Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Mawe GM, et al. Central canal neurons and autonomic integration. Gastroenterology. 2009 ↩︎
Nicholas MK, et al. Central canal architecture in the human spinal cord. J Comp Neurol. 2019 ↩︎
Kakita A, et al. Age-related changes in the human spinal cord. Brain Res. 2003 ↩︎
Molander C, et al. The laminar organization of the spinal cord. Prog Brain Res. 2002 ↩︎
Mack CM, et al. GABAergic neurons in lamina X. J Comp Neurol. 2001 ↩︎
Nagy GA, et al. Glutamatergic neurons in the spinal cord. J Neurosci. 2004 ↩︎
Barber RP, et al. Cholinergic neurons in the spinal cord. J Comp Neurol. 1984 ↩︎
Ren K, et al. Calcium-binding proteins in lamina X neurons. J Comp Neurol. 1993 ↩︎
Jessell TM. Neuronal specification in the spinal cord. Nat Rev Neurosci. 2000 ↩︎
Santoro M, et al. Development and obliteration of the central canal. Clin Neuropathol. 2013 ↩︎
Mawe GM. Visceral sensory processing in spinal cord. Gastroenterology. 2009 ↩︎
Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006 ↩︎
Fowler CJ, et al. Neural control of the urinary bladder. Physiol Rev. 2008 ↩︎
Cordero-Erausquin M, et al. Pain modulation and lamina X neurons. Front Neural Circuits. 2016 ↩︎
Fields HL, et al. Descending pain modulation. J Comp Neurol. 2005 ↩︎
Ransohoff RM, et al. Chemokine signaling in the spinal cord. Glia. 2009 ↩︎
Sarter M, et al. CSF signaling and neuronal function. Trends Neurosci. 2009 ↩︎
Derjean M, et al. Firing properties of lamina X neurons. J Neurophysiol. 2003 ↩︎
Keller AF, et al. Phasic firing in spinal neurons. Eur J Neurosci. 2008 ↩︎
Bennett BD, et al. Burst firing in autonomic neurons. J Neurosci. 2000 ↩︎
Cervero F, et al. Visceral afferents in lamina X. Pain. 2012 ↩︎
Portillo F, et al. Supraspinal inputs to lamina X. J Comp Neurol. 1998 ↩︎
Hantman AW, et al. Local circuits in lamina X. J Neurosci. 2004 ↩︎
Lovinger DM, et al. Glutamate receptors in the spinal cord. Neuropharmacology. 2007 ↩︎
Conn PJ, et al. Metabotropic glutamate receptors. Nat Rev Neurosci. 2005 ↩︎
Haddad EB, et al. Monoamine receptors in lamina X. Neuroscience. 2006 ↩︎
Wenning GK, et al. Multiple system atrophy. Lancet Neurol. 2004 ↩︎
Papp MI, et al. Oligodendroglial pathology in MSA. Brain. 1989 ↩︎
Chaudhuri KR, et al. Autonomic dysfunction in Parkinson's disease. Mov Disord. 2005 ↩︎
Braak H, et al. Lewy bodies in the spinal cord. Neurobiol Aging. 2003 ↩︎
Krassioukov AV, et al. Autonomic dysreflexia after spinal cord injury. Auton Neurosci. 2009 ↩︎
Gwak YS, et al. Neuropathic pain and lamina X neurons. Exp Neurol. 2006 ↩︎
Baltic M, et al. Autonomic dysfunction in ALS. Neurology. 2001 ↩︎
Van Damme P, et al. Excitotoxicity in ALS. Nat Rev Neurol. 2005 ↩︎
Cai Y, et al. Rodent models of central canal neurons. J Neurosci Methods. 2009 ↩︎
Masliah E, et al. Alpha-synuclein in transgenic mice. Science. 2000 ↩︎
Stuart GJ, et al. Brain slice electrophysiology. Pflugers Arch. 1993 ↩︎
Maucksch M, et al. Stem cell differentiation to spinal cord neurons. Stem Cells. 2009 ↩︎
Filippi M, et al. MRI in spinal cord disorders. Neurology. 2013 ↩︎
Reiber H, et al. CSF biomarkers in neurological diseases. Clin Chim Acta. 2003 ↩︎
Fontaine D, et al. Spinal cord stimulation. Neuromodulation. 2009 ↩︎
Malcangio M, et al. Pharmacological modulation of lamina X neurons. Pharmacol Rev. 2008 ↩︎
Bolam JP, et al. Immunohistochemistry for neuronal markers. Exp Brain Res. 2000 ↩︎
Köbbert C, et al. Retrograde tracing methods. Prog Neurobiol. 2000 ↩︎
Purves M, et al. Electrophysiology of spinal cord neurons. J Neurosci Methods. 2008 ↩︎